448 related articles for article (PubMed ID: 27632981)
1. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
Gill G; Bajwa H; Strouhal P; Buch HN
J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
[TBL] [Abstract][Full Text] [Related]
2. A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine.
Czarnywojtek A; Waligórska-Stachura J; Szczepanek E; Zgorzalewicz-Stachowiak M; Bereszyńska I; Kurdybacha P; Stangierski A; Harasymczuk J; Florek E; Waśko R; Ruchała M
Neuro Endocrinol Lett; 2012; 33(3):268-72. PubMed ID: 22635082
[TBL] [Abstract][Full Text] [Related]
3. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
[TBL] [Abstract][Full Text] [Related]
4. [Thyroid dysfunctions in patients with viral hepatitis treated with interferon-alpha].
Földes I; Dávid K; Horváth G; Osztrogonácz H; Jankovics K; Tolvaj G
Orv Hetil; 2004 Jun; 145(23):1211-6. PubMed ID: 15264588
[TBL] [Abstract][Full Text] [Related]
5. [Hepatitis C virus infection and thyroid diseases].
Broussolle C; Steineur MP; Bailly F; Zoulim F; Trépo C
Rev Med Interne; 1999 Sep; 20(9):766-73. PubMed ID: 10522298
[TBL] [Abstract][Full Text] [Related]
6. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
[TBL] [Abstract][Full Text] [Related]
7. Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C.
Falaschi P; Martocchia A; D'Urso R; Proietti A
J Endocrinol Invest; 1997 Jan; 20(1):24-8. PubMed ID: 9075068
[TBL] [Abstract][Full Text] [Related]
8. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
[TBL] [Abstract][Full Text] [Related]
11. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
[TBL] [Abstract][Full Text] [Related]
12. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.
Fernandez-Soto L; Gonzalez A; Escobar-Jimenez F; Vazquez R; Ocete E; Olea N; Salmeron J
Arch Intern Med; 1998 Jul; 158(13):1445-8. PubMed ID: 9665354
[TBL] [Abstract][Full Text] [Related]
15. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
Kozielewicz D; Zaleśna A; Dybowska D
Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
[TBL] [Abstract][Full Text] [Related]
16. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
17. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
[TBL] [Abstract][Full Text] [Related]
18. [Alpha interferon induced hyperthyroidism: a case report and review of the literature].
Maiga I; Valdes-Socin H; Thiry A; Delwaide J; Sidibe AT; Beckers A
Rev Med Liege; 2015; 70(7-8):390-4. PubMed ID: 26376567
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
Koh LK; Greenspan FS; Yeo PP
Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
[TBL] [Abstract][Full Text] [Related]
20. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
